ATE398623T1 - Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer - Google Patents

Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer

Info

Publication number
ATE398623T1
ATE398623T1 AT00966144T AT00966144T ATE398623T1 AT E398623 T1 ATE398623 T1 AT E398623T1 AT 00966144 T AT00966144 T AT 00966144T AT 00966144 T AT00966144 T AT 00966144T AT E398623 T1 ATE398623 T1 AT E398623T1
Authority
AT
Austria
Prior art keywords
carbamat
hexahydrofuro
ylsulfonyl
benzodioxol
furan
Prior art date
Application number
AT00966144T
Other languages
English (en)
Inventor
Piet Wigerinck
Guangyang Wang
Michael Eissenstat
John Erickson
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of ATE398623T1 publication Critical patent/ATE398623T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00966144T 1999-10-06 2000-10-06 Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer ATE398623T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15785099P 1999-10-06 1999-10-06

Publications (1)

Publication Number Publication Date
ATE398623T1 true ATE398623T1 (de) 2008-07-15

Family

ID=22565540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00966144T ATE398623T1 (de) 1999-10-06 2000-10-06 Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer

Country Status (26)

Country Link
US (2) US6649651B1 (de)
EP (1) EP1222192B8 (de)
JP (1) JP4951179B2 (de)
KR (1) KR100792391B1 (de)
CN (1) CN1191256C (de)
AP (1) AP1459A (de)
AT (1) ATE398623T1 (de)
AU (1) AU781656B2 (de)
BR (1) BR0014602A (de)
CA (1) CA2386850C (de)
CZ (1) CZ300031B6 (de)
DE (1) DE60039244D1 (de)
DK (1) DK1222192T3 (de)
ES (1) ES2307533T3 (de)
HK (1) HK1054746A1 (de)
HU (1) HU228938B1 (de)
IL (2) IL149005A0 (de)
MX (1) MXPA02003607A (de)
NO (1) NO327996B1 (de)
NZ (1) NZ518580A (de)
OA (1) OA12053A (de)
PL (1) PL204924B1 (de)
RU (1) RU2247123C2 (de)
SK (1) SK287153B6 (de)
WO (1) WO2001025240A1 (de)
ZA (1) ZA200202655B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12053A (en) * 1999-10-06 2006-05-02 Tibotec Pharm Ltd HexahydrofuroÄ2,3-bÜfuran-3-yl-N-ä3-Ä(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)aminoÜ-1-benzyl-2-hydroxypropylücarbamate as retroviral protease inhibitor.
CZ303139B6 (cs) * 2001-04-09 2012-04-25 Tibotec Pharmaceuticals Ltd. 2-(substituovaný amino)-benzoxazolsulfonamidový derivát, farmaceutická kompozice s jeho obsahem a zpusob in vitro inhibice retrovirové replikace
DE60234952D1 (de) * 2001-09-10 2010-02-11 Tibotec Pharm Ltd VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL
AU2003202914A1 (en) * 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
SI1517899T1 (sl) 2002-05-17 2008-02-29 Tibotec Pharm Ltd Substituirani benzoksazol sulfonamidi sirokega spektra, ki so HIV proteazni inhibitorji
CN101445493A (zh) * 2002-08-02 2009-06-03 泰博特克药品有限公司 广谱2-氨基-苯并噻唑磺酰胺类hiv蛋白酶抑制剂
WO2004060895A1 (ja) 2002-12-27 2004-07-22 Sumitomo Chemical Company, Limited ヘキサヒドロフロフラノール誘導体の製造方法、その中間体及びその製造方法
WO2005087728A1 (en) 2004-03-11 2005-09-22 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
TWI383975B (zh) 2004-03-31 2013-02-01 Tibotec Pharm Ltd 製備(3R,3aS,6aR)六氫-呋喃并〔2,3-b〕呋喃-3-醇之方法
KR100698291B1 (ko) * 2004-12-29 2007-03-22 엘지전자 주식회사 조명계
AU2006217922B2 (en) 2005-02-25 2012-04-05 Janssen Sciences Ireland Uc Protease inhibitor precursor synthesis
EP2049506B2 (de) 2006-07-07 2024-05-08 Gilead Sciences, Inc. Modulatoren der pharmakokinetischen eigenschaften von therapeutika
CA2658545A1 (en) * 2006-07-24 2008-01-31 Gilead Sciences, Inc. Bisfuranyl protease inhibitors
SI2089371T1 (sl) 2006-11-09 2011-05-31 Tibotec Pharm Ltd Postopki za pripravo heksahidrofuro(2,3-b)furan-3-ola
EP2491785A1 (de) * 2006-11-21 2012-08-29 Purdue Research Foundation Verfahren und Zusammensetzungen zur Behandlung von HIV-Infektionen
LT2487166T (lt) 2007-02-23 2016-11-10 Gilead Sciences, Inc. Terapinių agentų farmakokinetinių savybių moduliatoriai
US7981929B2 (en) * 2007-03-16 2011-07-19 Sequoia Pharmaceuticals, Inc. Benzofuran derived HIV protease inhibitors
CA2692331A1 (en) 2007-07-06 2009-01-15 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
CA2710679A1 (en) 2008-01-04 2009-07-16 Gilead Sciences, Inc. Inhibitors of cytochrome p450
WO2009091941A1 (en) * 2008-01-17 2009-07-23 Purdue Research Foundation Small molecule inhibitors of hiv proteases
US8791135B2 (en) 2008-07-01 2014-07-29 Purdue Research Foundation Nonpeptide HIV-1 protease inhibitors
WO2010006050A1 (en) * 2008-07-09 2010-01-14 Purdue Research Foundation Hiv protease inhibitors and methods for using
CA2784530C (en) 2009-12-21 2018-05-22 Janssen R&D Ireland Degradable removable implant for the sustained release of an active compound
DK2643326T3 (en) 2010-11-23 2017-01-09 Mylan Laboratories Ltd A process for the preparation of (3R, 3aS, 6aR) -hexahydrofuro [2,3-b] furan-3-ol
JPWO2014024898A1 (ja) 2012-08-09 2016-07-25 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2123065T3 (es) * 1992-08-25 1999-01-01 Searle & Co Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
DE69415326T2 (de) * 1993-08-24 1999-06-02 G.D. Searle & Co., Chicago, Ill. Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
WO1999067254A2 (en) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
WO1999067417A2 (en) 1998-06-23 1999-12-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Fitness assay and associated methods
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
OA12053A (en) * 1999-10-06 2006-05-02 Tibotec Pharm Ltd HexahydrofuroÄ2,3-bÜfuran-3-yl-N-ä3-Ä(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)aminoÜ-1-benzyl-2-hydroxypropylücarbamate as retroviral protease inhibitor.

Also Published As

Publication number Publication date
AU781656B2 (en) 2005-06-02
HUP0203130A2 (hu) 2003-01-28
HUP0203130A3 (en) 2005-01-28
JP2003511383A (ja) 2003-03-25
DK1222192T3 (da) 2008-10-20
PL204924B1 (pl) 2010-02-26
US6649651B1 (en) 2003-11-18
CZ20021419A3 (cs) 2002-10-16
IL149005A0 (en) 2002-11-10
ES2307533T3 (es) 2008-12-01
KR100792391B1 (ko) 2008-01-08
NO20021598D0 (no) 2002-04-04
CZ300031B6 (cs) 2009-01-14
NO20021598L (no) 2002-05-29
HK1054746A1 (en) 2003-12-12
SK5702002A3 (en) 2003-01-09
MXPA02003607A (es) 2003-07-28
WO2001025240A1 (en) 2001-04-12
SK287153B6 (sk) 2010-01-07
EP1222192B8 (de) 2008-10-01
DE60039244D1 (de) 2008-07-31
RU2247123C2 (ru) 2005-02-27
US7157495B2 (en) 2007-01-02
CA2386850C (en) 2010-03-30
CN1191256C (zh) 2005-03-02
NO327996B1 (no) 2009-11-02
PL354351A1 (en) 2004-01-12
OA12053A (en) 2006-05-02
HU228938B1 (hu) 2013-06-28
KR20020067503A (ko) 2002-08-22
EP1222192A1 (de) 2002-07-17
ZA200202655B (en) 2003-09-23
IL149005A (en) 2006-12-31
CN1407987A (zh) 2003-04-02
CA2386850A1 (en) 2001-04-12
EP1222192B1 (de) 2008-06-18
JP4951179B2 (ja) 2012-06-13
NZ518580A (en) 2004-01-30
AP1459A (en) 2005-08-22
BR0014602A (pt) 2002-06-11
US20050261364A1 (en) 2005-11-24
AP2002002472A0 (en) 2002-06-30
AU7663800A (en) 2001-05-10

Similar Documents

Publication Publication Date Title
ATE398623T1 (de) Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer
DE60036365D1 (de) Klappankersystem für einen schutzschalter
DE50007021D1 (de) Handwerkzeugmaschine
DE60036411D1 (de) Schlagwerkzeug
ITBO990171A0 (it) Macchina depallettizzatrice .
ID29961A (id) Alat penakar
DE60014258D1 (de) Taillenbandverstellvorrichtung
DE50010271D1 (de) Handwerkzeugmaschine
ID26595A (id) Alat pemilah
ATE265449T1 (de) 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridin wirksam als herbizide
DE50204164D1 (de) Gleisbaumaschine
NO20013338L (no) Bis-aminosyresulfonamider inneholdende N-terminalt en substituert benzylgruppe som HIV-proteaseinhibitorer
ID24511A (id) Alat saklar
DE60008492D1 (de) Griffanordnung für koffer
DE50010145D1 (de) Handwerkzeugmaschine
DE60002404D1 (de) Verbessertes handwerkzeug
AU2003243248A8 (en) Nanolithography molecular beam machine
FI4404U1 (fi) Liitosyhde
ES1039097Y (es) Maquina barredora-aspiradora industrial.
DE50014406D1 (de) Handwerkzeugmaschine
FI4195U1 (fi) Siirto- ja kuljetusväline
FI991290A0 (fi) Siirto- ja kuljetusväline
ITMC990046A0 (it) Gioco a pronostici.
FI3926U1 (fi) Kaasupesuri
BR1100661A (pt) Compostos inibidores de protease retroviral

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties